Medtronic announces final exchange ratio for MiniMed shares
Medtronic plc commenced an exchange offer on September 14, 2026, under which up to 225,361,295 newly issued MiniMed shares may be exchanged for Medtronic common shares. On October 7, 2026 the company announced the final ratio — 4.5939 MiniMed shares for each Medtronic share, which determines the size of the future issuance and the potential reduction of Medtronic shares.
Key points
- On September 14, 2026 Medtronic launched an exchange offer, proposing to swap up to 225,361,295 new MiniMed shares for Medtronic common stock.
- Accepted Medtronic common shares will be repurchased and cancelled, potentially reducing the number of shares outstanding and may boost earnings per share (EPS).
- If Medtronic shares are successfully accepted, their cancellation will lower shares outstanding, which, with unchanged earnings, could raise EPS.
What happened
On September 14, 2026 Medtronic launched an exchange offer, proposing to swap up to 225,361,295 new MiniMed shares for Medtronic common stock. In a press release on October 7, 2026 the final ratio was confirmed — 4.5939 MiniMed shares for each Medtronic share accepted.
Why it matters to investors
Accepted Medtronic common shares will be repurchased and cancelled, potentially reducing the number of shares outstanding and may boost earnings per share (EPS). At the same time, new MiniMed shares will be issued in the amount specified in the offer, which could dilute existing MiniMed owners.
When it could be beneficial
If Medtronic shares are successfully accepted, their cancellation will lower shares outstanding, which, with unchanged earnings, could raise EPS. The fixed ratio of 4.5939 gives participants certainty about the number of MiniMed shares they will receive.
Risks and uncertainties
If the offer is oversubscribed, the number of Medtronic common shares accepted may be less than the number of applications, because proportional allocation (proration) is applied.
What to watch
Later reports on the exchange offer should show how many Medtronic common shares were accepted and how many new MiniMed shares were issued. These data are key for assessing the impact on capital structure.
Original sources
Cite this article
The fingerprint identifies the exact version of each original that the article was written from; the original stays at its source.
Follow Medtronic
A notification in your browser or on your phone when we publish about Medtronic. Free, no email, no account, no app.
Prepared by AI from official company documents; automatic checks and an AI editor review it before publication, and not every article is read by a person. This is not investment advice. Editorial standards
